(AKT.L) Ark Therapeutics Group PLC Buy/Sell

RNS Number : 8990I J O Hambro Capital Management Ld 19 March 2010

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the Takeover Code)

1. KEY INFORMATION
Name of person dealing (Note 1) J O HAMBRO CAPITAL MANAGEMENT

Company dealt in ARK THERAPEUTICS GROUP PLC
Class of relevant security to which ORDINARY

the dealings being disclosed relate(Note 2)
Date of dealing 18 MARCH 2010
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long Short

Number Number
(%)
(%)
(1) Relevant securities 21,959,450

10.52

(2) Derivatives (other than options) (3) Options and agreements to purchase/sell
Total 21,959,450

10.52
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)0
Class of relevant security: Long Short

Number Number
(%)
(%)

(1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total

(c) Rights to subscribe (Note 3)

Class of relevant security: Details

3. DEALINGS (Note 4)
(a) Purchases and sales

Purchase/sale Number of securities Price per unit(Note 5)
PURCHASE 575,063 200,000 @ 12.125p
375,063 @ 12.375p
(b) Derivatives transactions (other than options)
Product name, Long/short(Note 6) Number of Price per unit(Note 5)
e.g. CFD securities(Note 7)

(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of securities Exercise Type, e.g. American, Expiry Option money
e.g. call option purchasing, varying to which the option price European etc. date paid/received per
etc. relates(Note 7) unit(Note 5)
(ii) Exercising

Product name, e.g. call option Number of securities Exercise price per
unit(Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction(Note 8) Details Price per unit (if applicable)(Note

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 19 MARCH 2010
Contact name MARK PURNELL
Telephone number 020 7747 8952

If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection(Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS The company news service from the London Stock Exchange

RETKMGMFVLNGGZM

RNS Number : 8814I Aviva PLC 19 March 2010

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

1. KEY INFORMATION
Name of person dealing (Note 1) AVIVA PLC AND ITS SUBSIDIARIES
Company dealt in ARK THERAPEUTICS GROUP PLC
Class of relevant security to which the ORD GBP0.01

dealings being disclosed relate(Note 2)
Date of dealing 18 MARCH 2010
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of
relevant security dealt in(Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 8,295,874 3.974% 0 0%
(2) Derivatives (other than options) 0 0% 0 0%
(3) Options and agreements to purchase/sell 0 0% 0 0%
Total 8,295,874 3.974% 0 0%
(b) Interests and short positions in relevant securities of the company, other than
the class dealt in(Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities 0 0% 0 0%
(2) Derivatives (other than options) 0 0% 0 0%
(3) Options and agreements to purchase/sell 0 0% 0 0%
Total 0 0% 0 0%
(c) Rights to subscribe (Note 3)

Class of relevant security: Details

3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 5)

SALE 12,281 GBP0.115000

(b) Derivatives transactions (other than options)

Product name, e.g. CFD Long/short (Note 6) Number of securities Price per unit (Note
(Note 7) 5)

(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,e.g. call option Writing, selling, Number of securities Exercise price Type, e.g. American, Expiry date Option money
purchasing, varying to which the option European etc. paid/received per
etc. relates (Note 7) unit (Note 5)

(ii) Exercising

Product name, e.g. call option Number of securities Exercise price per unit
(Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the Takeover Code)

1. KEY INFORMATION
Name of person dealing(Note 1) INVESCO LIMITED
Company dealt in ARK THERAPUTICS GROUP PLC
Class of relevant security to which the dealings being disclosed ORDINARY 1p SHARES

relate(Note 2)
Date of dealing 18 MARCH 2010

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 5,787,980 2.77%

(2) Derivatives (other than options) (3) Options and agreements to purchase/sell
Total 5,787,980 2.77%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)

(1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total

(c) Rights to subscribe (Note 3)
Class of relevant security: Details

3. DEALINGS (Note 4)

(a) Purchases and sales
Purchase/sale Number of securities Price per unit(Note 5)
Sale 774,325 0.12 GBP

(b) Derivatives transactions (other than options)
Product Long/short(Note 6) Number of securities(Note 7) Price per unit(Note 5)

name,e.g. CFD

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying
Product Writing, selling, Number of securities Exercise Type, e.g. American, Expiry

Option
name,e.g. call purchasing, varying to which the option price European etc. date

moneypaid/received
option etc. relates(Note 7)

per unit(Note 5)

(ii) Exercising
Product name, e.g. call option Number of securities Exercise price per unit(Note 5)

(d) Other dealings (including new securities) (Note 4)
Nature of transaction(Note 8) Details Price per unit (if applicable)()(Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting rights
or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) YES/NO
Date of disclosure 19 MARCH 2010
Contact name ON BEHALF OF INVESCO LIMITED
Telephone number 01491 416381

If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection(Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

RNS Number : 8476I Piper Jaffray Ltd 19 March 2010

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

1. KEY INFORMATION
Name of exempt principal trader Piper Jaffray Ltd.
Company dealt in Ark Therapeutics Group plc

Class of relevant security to which the dealings Ord 1p being disclosed relate(Note 1)
Date of dealing 18 March 2010
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)
Long Short

Number Number
(%)
(%)
(1) Relevant securities 178,839

0.09%

(2) Derivatives (other than options) (3) Options and agreements to purchase/sell
Total 178,839

0.09%
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)
Class of relevant security: Long Short

Number Number
(%)
(%)

(1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total

(c) Rights to subscribe (Note 2)

Class of relevant security: Details

3. DEALINGS (Note 3)
(a) Purchases and sales

Purchase/sale Number of securities Price per unit(Note 4)
Buy 2,000 11.00p
(b) Derivatives transactions (other than options)
Product name, Long/short(Note 5) Number of Price per unit(Note 4)
e.g. CFD securities(Note 6)

(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of securities Exercise Type, e.g. American, Expiry Option money
e.g. call option purchasing, varying to which the option price European etc. date paid/received per
etc. relates(Note 6) unit(Note 4)
(ii) Exercising

Product name, e.g. call option Number of securities Exercise price per
unit(Note 4)

(d) Other dealings (including new securities) (Note 3)

Nature of transaction(Note 7) Details Price per unit (if applicable)(Note

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 38.5(b) attached? (Note 8) NO
Date of disclosure 19 March 2010
Contact name Norman Gould
Telephone number 020 3142 8780

Name of offeree/offeror with which connected Ark Therapeutics Group plc
Nature of connection(Note 9) Adviser and broker

Notes

The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS The company news service from the London Stock Exchange

EMMUKRBRRKAOARR